ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO741

Routine Office Blood Pressure and All-Cause Mortality Among US Veterans With CKD

Session Information

Category: Hypertension and CVD

  • 1502 Hypertension and CVD: Clinical‚ Outcomes‚ and Trials

Authors

  • Yamada, Masaaki, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
  • Sambharia, Meenakshi, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
  • Griffin, Benjamin R., University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
  • Swee, Melissa L., Iowa City VA Medical Center, Iowa City, Iowa, United States
  • Reisinger, Heather, Iowa City VA Medical Center, Iowa City, Iowa, United States
  • Lund, Brian C., Iowa City VA Medical Center, Iowa City, Iowa, United States
  • Jalal, Diana I., Iowa City VA Medical Center, Iowa City, Iowa, United States
Background

Intensive blood pressure control has been shown to reduce the risk of death in individuals at high risk of cardiovascular disease. Data regarding blood pressure control are limited in chronic kidney disease (CKD). Here, we examined the association of different office blood pressure categories with all-cause mortality in a national sample of US Veterans stratified by kidney function

Methods

Veterans with prevalent hypertension (as defined by i. International Classification of Disease-10 codes related to hypertension, ii. prescription of antihypertensive drugs, or iii. ≥2 office BP of ≥130/90 mmHg) who had ≥2 systolic blood pressure (SBP) readings between 2016-2017 with a follow-up through March 2021 were included. Those with mean SBP <100 mmHg were excluded. CKD categories were defined based on estimated glomerular filtration rate (eGFR): <30, 30-60, and >60 mL/min/1.73m2. We examined the association of mean SBP control (3 groups: <120, 120-129, and ≥130 mmHg) with all-cause mortality by using time-dependent Cox regression models adjusted for demographics, body mass index, and comorbid conditions. SBP was modeled as a time-dependent variable

Results

Total 30,782,873 hypertensive Veterans had eGFR available were included in our analyses. Of those, 1.3% (n=394,132) had eGFR <30 mL/min/1.73m2 at baseline; 18.4% (n=5,649,379) had 30-60 mL/min/1.73m2; and 80.4% (n=24,739,362) had >60 mL/min/1.73m2. Mean SBP <120 and 120-129 mmHg categories were associated with reduced mortality compared to ≥130 mmHg (Table 1), although SBP category 120-129 mmHg was associated with the least risk of all-cause mortality (Table 1). These findings were notable in Veterans across all eGFR categories including those with stage 4 CKD

Conclusion

Mean SBP of 120-129 mmHg was indeed associated with lower mortality than <120 mmHg, and both 120-129 and <120 were superior to SBP ≥130 mmHg among all Veterans including advanced CKD

Table 1. Mortality risk
Kidney function, eGFR (mL/min/1.73m2)Mean systolic blood pressure (mmHg)Hazard ratio95% confidence interval
eGFR <30, n=394,132 (1.3%)<1200.860.84-0.89
120-1290.630.61-0.66
≧1301 (reference) 
eGFR 30-60, n=5,649,379 (18.4%)<1200.910.90-0.92
120-1290.650.64-0.66
≧1301 (reference) 
eGFR >60, n=24,739,362 (80.4%)<1200.930.92-0.93
120-1290.670.66-0.67
≧1301 (reference) 

Funding

  • Veterans Affairs Support